The Microbiome Business & Science Briefing
MicrobimeTimes
Reporting on The Latest Microbiome Business & Scientific Developments
TRENDING
Microbial systems are a black box. We created Microbial INtelligence Explorer to “MINE” their secrets• Microbiotica Raises $48 Million Series C to Advance Pipeline into Phase 2 Clinical Development• Prokarium: Leading the Evolution of Bacterial Immunotherapy, the Next Frontier in Cancer Treatment• Claude Discovers Novel Enzyme System with CRISPR-like Repeats• New Clinical Study Aims to Find Out if FMT capsules could help better manage anorexia• MaaT Pharma Provides Update on MaaT013 (Xervyteg®) Potential Development Plan Following CHMP Negative Opinion After Re-examination•

Category: Clinical & Manufacturing

The Human Microbiome: A Global Overview of Clinical Trials Activity
Clinical & Manufacturing

The Human Microbiome: A Global Overview of Clinical Trials Activity

FEB 5, 2019
Evelo Announces Dosing of First Patient in Phase 2a Clinical Trial in Patients with Metastatic Melanoma
Clinical & Manufacturing

Evelo Announces Dosing of First Patient in Phase 2a Clinical Trial in Patients with Metastatic Melanoma

JAN 29, 2019
Second Genome Doses First Patient In Phase 2 Clinical Study Of SGM-1019 For NASH
Clinical & Manufacturing

Second Genome Doses First Patient In Phase 2 Clinical Study Of SGM-1019 For NASH

JAN 24, 2019
Da Volterra Announces Enrollment of First Patients in SHIELD, a Phase 2 Clinical Trial with DAV132, a Novel Microbiota Protective Therapy
Clinical & Manufacturing

Da Volterra Announces Enrollment of First Patients in SHIELD, a Phase 2 Clinical Trial with DAV132, a Novel Microbiota Protective Therapy

JAN 6, 2019
BMS and Vedanta Announce Clinical Collaboration to Evaluate OPDIVO and VE800 in Patients with Advanced or Metastatic Cancers
Clinical & Manufacturing

BMS and Vedanta Announce Clinical Collaboration to Evaluate OPDIVO and VE800 in Patients with Advanced or Metastatic Cancers

DEC 10, 2018
MaaT Pharma Presents Positive Phase 1b/2a Study Results in Acute Myeloid Leukemia Patients
Clinical & Manufacturing

MaaT Pharma Presents Positive Phase 1b/2a Study Results in Acute Myeloid Leukemia Patients

DEC 3, 2018
Vedanta Biosciences Announces Initiation of Phase 1 Clinical Study with Janssen of Microbiome-Derived Product Candidate for IBD
Clinical & Manufacturing

Vedanta Biosciences Announces Initiation of Phase 1 Clinical Study with Janssen of Microbiome-Derived Product Candidate for IBD

NOV 27, 2018
Synthetic Biologics Announces Positive Outcome of End-of-Phase 2 Meeting with FDA on SYN-004 (ribaxamase) Development
Clinical & Manufacturing

Synthetic Biologics Announces Positive Outcome of End-of-Phase 2 Meeting with FDA on SYN-004 (ribaxamase) Development

NOV 22, 2018
4D Pharma plc Announces First Patient Enrolment in Blautix IBS Phase II study
Clinical & Manufacturing

4D Pharma plc Announces First Patient Enrolment in Blautix IBS Phase II study

NOV 9, 2018
MaaT Pharma Announces First Patient Dosed in Phase 2 Clinical Trial of Lead Product MaaT013, a First-in-Class Biotherapeutic to Treat Acute GvHD
Clinical & Manufacturing

MaaT Pharma Announces First Patient Dosed in Phase 2 Clinical Trial of Lead Product MaaT013, a First-in-Class Biotherapeutic to Treat Acute GvHD

OCT 15, 2018
Ilya Pharma Raises Additional €3 million to Take Novel ATMP Through to Phase II for Wound Care
Clinical & Manufacturing

Ilya Pharma Raises Additional €3 million to Take Novel ATMP Through to Phase II for Wound Care

SEP 14, 2018